Edition:
United States

HTG Molecular Diagnostics Inc (HTGM.OQ)

HTGM.OQ on NASDAQ Stock Exchange Capital Market

5.06USD
16 Feb 2018
Change (% chg)

$0.01 (+0.20%)
Prev Close
$5.05
Open
$4.90
Day's High
$5.46
Day's Low
$4.76
Volume
278,127
Avg. Vol
224,077
52-wk High
$13.24
52-wk Low
$1.20

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 3.72 -0.464
Jun '17 1.76 -0.598
Mar '17 1.37 -0.730
FY 2016 Dec '16 1.46 -0.757
Sep '16 0.91 -0.920
Jun '16 1.90 -0.976
Mar '16 0.87 -1.020
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 2 5.10 5.60 4.60 3.80
Quarter Ending Jun-18 2 5.20 5.60 4.80 4.10
Year Ending Dec-18 2 21.80 22.59 21.00 16.08
Earnings (per share)
Quarter Ending Mar-18 2 -0.35 -0.19 -0.52 -0.83
Quarter Ending Jun-18 2 -0.33 -0.14 -0.52 -0.78
Year Ending Dec-18 2 -1.28 -0.60 -1.96 -2.02
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 46.02 34.43
P/E High - Last 5 Yrs. -- 82.48 46.75
P/E Low - Last 5 Yrs. -- 20.71 24.14
Beta -- 0.86 0.81
Price to Sales (TTM) 8.48 5.07 8.57
Price to Book (MRQ) -- 4.13 5.14
Price to Tangible Book (MRQ) -- 6.12 6.30
Price to Cash Flow (TTM) -- 25.59 25.75
% Owned Institutions 7.93 27.40 2.33

Dividends

  Company industry sector
Dividend Yield -- 0.73 1.52
Dividend Yield - 5 Year Avg -- 0.63 2.01
Dividend 5 Year Growth Rate -- 5.73 5.27
Payout Ratio(TTM) -- 16.27 42.77

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 307.43 14.52 9.45
Sales (TTM) vs TTM 1 Yr. Ago 69.98 8.93 7.30
Sales - 5 Yr. Growth Rate -- 4.23 10.21
EPS (MRQ) vs Qtr. 1 Yr. Ago 49.59 4.41 20.15
EPS (TTM) vs TTM 1 Yr. Ago 31.99 -- --
EPS - 5 Yr. Growth Rate -- 4.80 11.48
Capital Spending - 5 Yr. Growth Rate -- 10.50 14.76

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 0.94 1.70 2.42
Current Ratio (MRQ) 1.03 2.21 3.38
LT Debt to Equity (MRQ) -- 31.70 11.85
Total Debt to Equity (MRQ) -- 42.57 15.12
Interest Coverage (TTM) -14.56 35.60 38.50

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 41.59 57.37 54.90
Gross Margin - 5 Yr. Avg. -- 55.94 52.64
EBITD Margin (TTM) -240.64 -- --
EBITD - 5 Yr. Avg -- 14.84 9.86
Operating Margin (TTM) -256.04 8.70 1.25
Operating Margin - 5 Yr. Avg. -- 7.08 5.07
Pre-Tax Margin (TTM) -273.11 9.40 2.12
Pre-Tax Margin - 5 Yr. Avg. -- 6.37 5.33
Net Profit Margin (TTM) -273.19 6.14 -1.38
Net Profit Margin - 5 Yr. Avg. -- 3.83 1.62
Effective Tax Rate (TTM) -- 24.96 22.03
Effective Tax Rate - 5 Yr. Avg. -- 20.91 24.20

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 14,532,104 819,569,446
Net Income/Employee (TTM) -- 1,161,035 95,804,981
Receivable Turnover (TTM) 4.43 4.98 5.40
Inventory Turnover (TTM) 3.11 4.24 3.48
Asset Turnover (TTM) 0.41 0.74 0.90

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -112.35 2.58 10.68
Return on Assets - 5 Yr. Avg. -- 5.49 12.00
Return on Investment (TTM) -265.58 9.08 13.54
Return on Investment - 5 Yr. Avg. -- 7.30 15.72
Return on Equity (TTM) -- 13.32 14.80
Return on Equity - 5 Yr. Avg. -- 10.22 16.91
  1 Year 3 Year 5 Year
Sales % 27.00 31.78 --
EPS (TTM) % 27.22 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for HTG Molecular Diagnostics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 13.13%
# of Holders: 24
Total Shares Held: 3,656,727
3 Mo. Net Change: 1,617,409
# New Positions: 5
# Closed Positions: 7
# Increased Positions: 10
# Reduced Positions: 10
# Net Buyers: 0
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.